Top

Reactions Weekly

Published in:

01-09-2023 | Sunitinib | Case report

Sunitinib/zoledronic-acid

Osteonecrosis of the jaw and lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Golu MV, et al. Recurrent submandibular fistula after Sunitinib treatment in a patient with renal cell carcinoma: a case report. Medicine and Pharmacy Reports 96: 323-327, No. 3, 2023. Available from: URL: http://doi.org/10.15386/mpr-2502

Title: Sunitinib/zoledronic-acid
Osteonecrosis of the jaw and lack of efficacy: case report
Publication date: 01-09-2023
Publisher: Springer International Publishing
Keywords: Sunitinib
Osteonecrosis
Kidney Cancer
Kidney Cancer
Kidney Cancer
Metastasis
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-45700-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Sunitinib/zoledronic-acid

Osteonecrosis of the jaw and lack of efficacy: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Atorvastatin

Antenatal corticosteroids increase risk of serious infections during infancy

Calcium-regulators/dexamethasone/electrolytes

Cyclophosphamide/pirarubicin/tacrolimus

Apixaban/edoxaban/nintedanib

Ipilimumab/nivolumab